Posted On: 10/28/2015 5:15:39 PM
Post# of 30066
Good point.
I now recall that the last two presentations had a new banner above the Eltoprazine slides.
"Amarantus Evaluating Strategic Options for Eltoprazine Phase 2b Study"
In other words, we are putting the trial on hold to focus on ESS and Eltoprazine is for sale.
Lowe may not have liked that. Especially if they wanted to cancel his consulting agreement too.
I now recall that the last two presentations had a new banner above the Eltoprazine slides.
"Amarantus Evaluating Strategic Options for Eltoprazine Phase 2b Study"
In other words, we are putting the trial on hold to focus on ESS and Eltoprazine is for sale.
Lowe may not have liked that. Especially if they wanted to cancel his consulting agreement too.
Quote:
or he was not fond of selling?
(0)
(0)
